Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria.

Cidofovir (HPMPC; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine) is a nucleotide analog with activity against human cytomegalovirus (CMV). A phase I/II dose escalation trial was conducted with asymptomatic human immunodeficiency virus (HIV)-infected patients with CMV viruria to determine its...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Polis, M A, Spooner, K M, Baird, B F, Manischewitz, J F, Jaffe, H S, Fisher, P E, Falloon, J, Davey, R T, Kovacs, J A, Walker, R E
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162647/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7785989/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.4.882
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!